COVID-19: The Immune Responses and Clinical Therapy Candidates.
Int J Mol Sci
; 21(15)2020 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: covidwho-693568
ABSTRACT
The pandemic of coronavirus disease 2019 (COVID-19), with rising numbers of patients worldwide, presents an urgent need for effective treatments. To date, there are no therapies or vaccines that are proven to be effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several potential candidates or repurposed drugs are under investigation, including drugs that inhibit SARS-CoV-2 replication and block infection. The most promising therapy to date is remdesivir, which is US Food and Drug Administration (FDA) approved for emergency use in adults and children hospitalized with severe suspected or laboratory-confirmed COVID-19. Herein we summarize the general features of SARS-CoV-2's molecular and immune pathogenesis and discuss available pharmacological strategies, based on our present understanding of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) infections. Finally, we outline clinical trials currently in progress to investigate the efficacy of potential therapies for COVID-19.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Infecções por Coronavirus
/
Imunidade Adaptativa
/
Betacoronavirus
Tipo de estudo:
Estudo prognóstico
Tópicos:
Vacinas
Limite:
Humanos
Idioma:
Inglês
Ano de publicação:
2020
Tipo de documento:
Artigo
País de afiliação:
Ijms21155559
Similares
MEDLINE
...
LILACS
LIS